The Pharmaceutical R&D Outsourcing Market was valued at USD 84.01 billion in 2023, and is expected to reach USD 150.04 billion by 2029, rising at a CAGR of 10.15% The global pharmaceutical R&D ...

With pharmaceutical companies heavily investing in R&D and precision medicine, the demand for high-quality specialty APIs is ...

The Novo Nordisk Foundation does not plan to step in to prop up a global health sector reeling from a freeze on U.S.-funded ...

This article is authored by Ranjit Barshikar, CEO, QbD International, CGMP Consulting, United Nations Adviser.

Pharma is missing opportunities to maximise the benefits of applying a digital approach on a global scale, says Gregg Fisher. Managing for global impact continues to be a challenge for many ...

Simon-Kucher's industry study reveals barriers and success factors for improving global pricing and marketing access ...